Heart failure (HF) remains a major cause of morbidity, mortality, and increased healthcare costs worldwide, and is recognized as the result of progressive cardiovascular-kidney-metabolic (CKM) syndrome. Obesity, type 2 diabetes, chronic kidney disease, hypertension, and atherosclerotic cardiovascular disease frequently...
R. Inciardi, A. Abdin, M. Abdelhamid et al.· European Journal of Heart Fa...· 0 citations
Therapeutic developments continue to reshape HF management across the spectrum of left ventricular ejection fraction, and support the transition from a predominantly phenotype-based approach towards a more personalized and biologically informed model of HF care.
Valentino Liguori, Angelica Rizzello, M. Adamo et al.· ESC Heart Failure· 0 citations
BACKGROUND
The Charlson comorbidity index (CCI) is a validated weighted measure of comorbidity burden, but has an unclear role in heart failure (HF).
OBJECTIVES
To characterize age-adjusted CCI (ACCI) in HF, its association with the use of guideline-directed medical therapy (GDMT) and with outcomes.
METHODS
In the...
Naba Farooqui, L. Benson, T. Thorvaldsen et al.· ESC Heart Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.